Status
Conditions
Study type
Funder types
Identifiers
About
The main aim of this study is to estimate the risks of certain adverse events in adults with Von Willebrand Disease treated with VEYVONDI. No study medicines will be provided to participants in this study.
Data from medical records of participants diagnosed with Von Willebrand Disease and treated with VEYVONDI will be evaluated during this study.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
102 participants in 1 patient group
Loading...
Central trial contact
Takeda Contact
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal